P.L. 97-414

TITLE: Orphan Drug Act

DATE: Jan. 4, 1983  
LENGTH: 44 p.  
ENACTED-BILL: 98 H.R. 5238  
STAT: 96 Stat. 2049.  
CONG-SESS: 97-2  

SUMMARY:
"To amend the Federal Food, Drug, and Cosmetic Act to facilitate the development of drugs for rare diseases and conditions, and for other purposes."
 
Drugs of limited commercial value, dev and approval

BILLS: 97 S. 2130; 97 H.R. 1937; 97 H.R. 5238; 97 H.R. 6444; 97 H.R. 6355; 97 S. 234; 97 S. 2311; 97 S. 255

REFERENCES:
 
DEBATE:
 
Congressional Record Vol. 128 (1982):
   Sept. 28, considered and passed House.
   Oct. 1, considered and passed Senate, amended.
   Dec. 14, House concurred in Senate amendment with an amendment.
   Dec. 16, Senate concurred in House amendment.
 
WEEKLY COMPILATION OF Presidential Documents, Vol. 19, No. 1 (1983):
   Jan. 4, Presidential statement.
 
 
PUBLICATIONS:
 
 
HOUSE HEARINGS: H501-75.
 
 
HOUSE COMMITTEE PRINTS: H502-17.
 
 
HOUSE HEARINGS: H361-23; H501-39.
 
 
SENATE HEARINGS: S521-69; S541-38.
 
 
HOUSE COMMITTEE PRINTS: H362-16.
 
 
SENATE REPORTS: S523-7 (No. 97-138, accompanying S. 255).
 
 
HOUSE HEARINGS: H361-90.
 
 
SENATE HEARINGS: S541-19; S541-25; S541-61; S541-64.
 
 
HOUSE COMMITTEE PRINTS: H362-4.
 
 
HOUSE REPORTS: H363-26 (No. 97-793, accompanying H.R. 6355); H363-28 (No. 97-840, pt. 1); H523-29 (No. 97-696, accompanying H.R. 6444).
 
 
SENATE REPORTS: S543-1 (No. 97-325, accompanying S. 234); S543-3 (No. 97-461, accompanying S. 2311).
 
 
HOUSE HEARINGS: H521-9; H701-28.